1. Analysis of Factors Associated with Long-Term Survival in Patients with Glioblastoma
- Author
-
C.V. Shankar Ganesh, Gopalakrishnan M Sasidharan, Aliasgar Moiyadi, A Sathia Prabhu, Sridhar Epari, Venkatesan Subeikshanan, Tejpal Gupta, Venkatesh S Madhugiri, Prakash Shetty, Akshat Dutt, V R Roopesh Kumar, Rakesh Jalali, and A S Ramesh
- Subjects
Male ,Oncology ,Time Factors ,Neutrophils ,Systemic inflammation ,Monocytes ,Leukocyte Count ,0302 clinical medicine ,Cancer Survivors ,DNA Modification Methylases ,Brain Neoplasms ,Medical record ,Age Factors ,Margins of Excision ,Middle Aged ,Prognosis ,Isocitrate Dehydrogenase ,Survival Rate ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Absolute neutrophil count ,Immunohistochemistry ,Female ,lipids (amino acids, peptides, and proteins) ,medicine.symptom ,Adult ,medicine.medical_specialty ,03 medical and health sciences ,Internal medicine ,Long term survival ,medicine ,Humans ,Lymphocyte Count ,Karnofsky Performance Status ,Retrospective Studies ,Performance status ,Platelet Count ,business.industry ,Tumor Suppressor Proteins ,DNA Methylation ,Eosinophil ,medicine.disease ,Eosinophils ,DNA Repair Enzymes ,Ki-67 Antigen ,Mutation ,Surgery ,Neurology (clinical) ,Tumor Suppressor Protein p53 ,Glioblastoma ,business ,030217 neurology & neurosurgery - Abstract
Background Some patients with glioblastoma multiforme (GBM) survive 3–5 years (or longer) after diagnosis. The goal of this study was to identify differences between the long-term survivors (LTS) and those who had a shorter overall survival (non-LTS groups). Methods This study was a retrospective analysis of prospectively maintained surgical databases. All patients who underwent safe maximal resection for GBM were included. Demographic, clinical, radiologic, and pathologic data were obtained from electronic medical records. Values of the biomarkers of systemic inflammation were computed from the preoperative hemogram reports. Patients with an overall survival (OS) ≥36 months were defined as the LTS group and were compared with the non-LTS groups (OS Results Patients in the LTS group were younger, had a better baseline performance status, and were more likely to have undergone near- or gross-total resection. LTS was associated with lower Ki67 labeling, MGMT methylation, IDH mutation, and lack of p53 overexpression. Several novel findings were generated by this study. A longer pretreatment duration of symptoms was associated with a longer OS. Higher pretreatment levels of the absolute neutrophil count, neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio, derived neutrophil-lymphocyte ratio and systemic index of inflammation, and lower levels of the absolute eosinophil count and eosinophil-lymphocyte ratio all correlated with a shorter OS. Conclusions Several differences were identified between the LTS and non-LTS groups. These differences will likely be incorporated into future prognostic models. They may also aid in differentiation between recurrent disease and treatment-related changes.
- Published
- 2021
- Full Text
- View/download PDF